7 Einträge |
Seite 1 / 1
![]() |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
PMID: 29146401 |
The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. |
Schliehe C, Flynn EK, Vilagos B, Richson U, Swaminathan S, Bosnjak B, Bauer L, Kandasamy RK, Griesshammer IM, Kosack L, Schmitz F, Litvak V, Sissons J, Lercher A, Bhattacharya A, Khamina K, Trivett AL, Tessarollo L, Mesteri I, Hladik A, Merkler D, Kubicek S, Knapp S, Epstein MM, Symer DE, Aderem A, Bergthaler A |
Nature immunology. 2014 Nov 24. pii: ni.3046. doi: 10.1038/ni.3046. pmc: PMC4320687. mid: NIHMS640091 |
PMID: 25419628 |
SU-E-T-547: Rotating Shield Brachytherapy (RSBT) for Cervical Cancer. |
Yang W, Kim Y, Liu Y, Wu X, Flynn R |
Medical physics. 2017 May 18. doi: 10.1118/1.4735636 |
PMID: 28518488 |
Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). |
Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, Tausch C, Dammann F, Baltzer PA, Fallenberg EM, Foschini MP, Dellas S, Knauer M, Malhaire C, Sonnenschein M, Boos A, Morris E, Varga Z |
Breast cancer research and treatment. 2018 Nov 30. doi: 10.1007/s10549-018-05071-1. pii: 10.1007/s10549-018-05071-1 |
PMID: 30506111 |
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). |
Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, Tausch C, Dammann F, Baltzer PA, Fallenberg EM, Foschini MP, Dellas S, Knauer M, Malhaire C, Sonnenschein M, Boos A, Morris E, Varga Z |
Breast cancer research and treatment. 2019 May 31. doi: 10.1007/s10549-019-05287-9. pii: 10.1007/s10549-019-05287-9 |
PMID: 31152325 |
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy. |
Panés J, Lindsay JO, Teich N, Lindgren S, Colombel JF, Cornillie F, Flynn HA, Huyck S, Stryszak P, Yao R, Philip G, Reinisch W |
Journal of Crohn's & colitis. pii: 5365571. doi: 10.1093/ecco-jcc/jjz048 |
PMID: 30809631 |
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. |
Kartsonaki C, Baillie JK, Barrio NG, Baruch J, Beane A, Blumberg L, Bozza F, Broadley T, Burrell A, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Elotmani L, Escher M, Farshait N, Goffard JC, Gonçalves BP, Hall M, Hashmi M, Sim Lim Heng B, Ho A, Jassat W, Pedrera Jiménez M, Laouenan C, Lissauer S, Martin-Loeches I, Mentré F, Merson L, Morton B, Munblit D, Nekliudov NA, Nichol AD, Singh Oinam BC, Ong D, Panda PK, Petrovic M, Pritchard MG, Ramakrishnan N, Ramos GV, Roger C, Sandulescu O, Semple MG, Sharma P, Sigfrid L, Somers EC, Streinu-Cercel A, Taccone F, Vecham PK, Kumar Tirupakuzhi Vijayaraghavan B, Wei J, Wils EJ, Ci Wong X, Horby P, Rojek A, Olliaro PL |
International journal of epidemiology. 2023 Feb 28. doi: 10.1093/ije/dyad012. pii: 7059267 |
PMID: 36850054 |
7 Einträge |
Seite 1 / 1
![]() |